ArticleActive
Billing and Coding: MolDX: Razor 14-Gene Lung Cancer Assay
A57170
Updated: December 31, 2025
Policy Summary
Billing for the Razor 14‑Gene Lung Cancer Assay requires reporting the appropriate CPT code and one unit of service (1 UOS), including the DEX Z‑Code™ identifier adjacent to the CPT code in specified claim fields for Part A and Part B (electronic and paper). An appropriate ICD‑10‑CM diagnosis code must also be reported; follow the referenced LCD (DL38284) for clinical coverage criteria.
Coverage Criteria Preview
Key requirements from the full policy
"Select and report the appropriate CPT code for the Razor 14‑Gene Lung Cancer Assay on the claim."
Sign up to see full coverage criteria, indications, and limitations.